Carlyle to exit China’s Concord Medical via founder-led privatization
The Carlyle Group is set to make a full exit from Concord Medical Services, a US-listed Chinese radiotherapy and diagnostic imaging center operator, in a take-private transaction initiated by the company’s chairman and CEO.
According to a statement, the founder-led proposed acquisition was priced at $1.73 per Class A ordinary share, or $5.19 per American Depository Share. This represents a premium of 33.8% to the company's...
More on Greater China
Latest News
Ex-CVC Asia head raises $200m SPAC
Generation Asia Acquisition, a special purpose acquisition company (SPAC) sponsored by Roy Kuan, formerly Asia managing partner at CVC Capital Partners, has raised USD 200m through a US offering.
Insight leads $56m Series C for India's M2P Fintech
India’s M2P Fintech, a software provider that connects banking infrastructure to consumer-facing technology platforms, has raised USD 56m in Series C funding led by Insight Partners.
BRV leads $140m Series C for Korea's Green Labs
BRV Capital Management has led a KRW 170bn (USD 140m) Series C round for Green Labs, a Korea-based agricultural technology start-up seeking to digitalise the food production value chain.
Vision Fund leads $150m round for China e-commerce enabler
Shoplazza, a China-based software-as-a-service (SaaS) provider specialising in cross-border e-commerce, has raised USD 150m in the first tranche of Series C led by SoftBank Vision Fund II.